Bremer Trust National Association’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bremer Trust National Association’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$140K	Buy	+1,128	New	+$167K	0.03%	291
2016 Q1	–	Sell	-1,893	Closed	-$266K	–	258
2015 Q4	$266K	Buy	1,893 +142	+8%	+$19.7K	0.08%	200
2015 Q3	$233K	Sell	1,751 -504	-22%	-$86.8K	0.08%	208
2015 Q2	$397K	Sell	2,255 -12	-0.5%	-$2.15K	0.12%	159
2015 Q1	$391K	Buy	2,267 +17	+0.8%	+$2.92K	0.12%	149
2014 Q4	$369K	Sell	2,250 -356	-14%	-$59.1K	0.12%	150
2014 Q3	$418K	Sell	2,606 -33	-1%	-$5.07K	0.14%	141
2014 Q2	$388K	Sell	2,639 -535	-17%	-$74.2K	0.14%	146
2014 Q1	$440K	Sell	3,174 -16	-0.5%	-$2.41K	0.16%	129
2013 Q4	$404K	Sell	3,190 -704	-18%	-$72.8K	0.15%	130
2013 Q3	$358K	Sell	3,894 -127	-3%	-$10.2K	0.15%	130
2013 Q2	$276K	Buy	+4,021	New	+$246K	0.12%	144

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bremer Trust National Association's JAZZ Position: Q4 2018 in Review

Bremer Trust National Association opened a new position in Jazz Pharmaceuticals (JAZZ) in Q4 2018: 1,128 shares worth $140K. The stake represents 0.03% of the portfolio and ranks #291 among its holdings. This is a return to the name: Bremer Trust National Association previously reported a position in JAZZ as recently as Q4 2015.

Bremer Trust National Association first reported a position in JAZZ in Q2 2013 and has held it in 12 quarters since. The position peaked at $440K in Q1 2014. 417 funds tracked by Wall St. Rank hold JAZZ as of Q4 2018.

Bremer Trust National Association held 1,128 shares of Jazz Pharmaceuticals worth $140K as of Q4 2018.
Jazz Pharmaceuticals was a new Bremer Trust National Association position in Q4 2018.
Jazz Pharmaceuticals made up 0.03% of Bremer Trust National Association's portfolio in Q4 2018, its #291 holding.
Bremer Trust National Association first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
Bremer Trust National Association's Jazz Pharmaceuticals position peaked at $440K in Q1 2014.
417 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q4 2018.

Based on Bremer Trust National Association's 13F filing for Q4 2018, filed 11 Feb 2019.